BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30251606)

  • 1. Do We have a Satisfactory Cell Viability Assay? Review of the Currently Commercially-Available Assays.
    Halim AB
    Curr Drug Discov Technol; 2020; 17(1):2-22. PubMed ID: 30251606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-content screening: imaging, analysis, and applications.
    Mattheakis L
    J Biomol Screen; 2013 Aug; 18(7):845-7. PubMed ID: 23881694
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of new technologies for cellular screening along the drug value chain.
    Möller C; Slack M
    Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated MALDI Target Preparation Concept: Providing Ultra-High-Throughput Mass Spectrometry-Based Screening for Drug Discovery.
    Winter M; Ries R; Kleiner C; Bischoff D; Luippold AH; Bretschneider T; Büttner FH
    SLAS Technol; 2019 Apr; 24(2):209-221. PubMed ID: 30074850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Simple Procedure for Creating Scalable Phenotypic Screening Assays in Human Neurons.
    Sridharan B; Hubbs C; Llamosas N; Kilinc M; Singhera FU; Willems E; Piper DR; Scampavia L; Rumbaugh G; Spicer TP
    Sci Rep; 2019 Jun; 9(1):9000. PubMed ID: 31227747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automation of a phospho-STAT5 staining procedure for flow cytometry for application in drug discovery.
    Malergue F; van Agthoven A; Scifo C; Egan D; Strous GJ
    J Biomol Screen; 2015 Mar; 20(3):416-21. PubMed ID: 25325258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Discovery Channel: microfluidics and microengineered systems in drug screening.
    Moraes C
    Integr Biol (Camb); 2015 Mar; 7(3):285-8. PubMed ID: 25677245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GloSensor assay for discovery of GPCR-selective ligands.
    Kumar BA; Kumari P; Sona C; Yadav PN
    Methods Cell Biol; 2017; 142():27-50. PubMed ID: 28964338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Based Assay Design for High-Content Screening of Drug Candidates.
    Nierode G; Kwon PS; Dordick JS; Kwon SJ
    J Microbiol Biotechnol; 2016 Feb; 26(2):213-25. PubMed ID: 26428732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for content--the evolution of high throughput.
    Dove A
    Nat Biotechnol; 2003 Aug; 21(8):859-64. PubMed ID: 12894197
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-based assays--Informa Life Sciences' Fifth Annual Conference--Label-free cell-based assays and high-content analysis in drug discovery.
    Gasparri F
    IDrugs; 2010 Aug; 13(8):523-6. PubMed ID: 20721820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Screening to Identify Anesthetic Ligands Using Xenopus laevis Tadpoles.
    Woll KA; Eckenhoff RG
    Methods Enzymol; 2018; 602():177-187. PubMed ID: 29588028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous Locus Reporter Assays.
    Liu Y; Hermes J; Li J; Tudor M
    Methods Mol Biol; 2018; 1755():163-177. PubMed ID: 29671270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of Cell Viability Assays for Drug Sensitivity Screens.
    Larsson P; Parris TZ
    Methods Mol Biol; 2023; 2644():287-302. PubMed ID: 37142929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward high-throughput drug screening on a chip-based parallel affinity separation platform.
    Ohlson S; Duong-Thi MD; Bergström M; Fex T; Hansson L; Pedersen L; Guazotti S; Isaksson R
    J Sep Sci; 2010 Sep; 33(17-18):2575-81. PubMed ID: 20730836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymerase assays for lead discovery: An overall review of methodologies and approaches.
    Nasiri AH; Nasiri HR
    Anal Biochem; 2018 Dec; 563():40-50. PubMed ID: 30291837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-step pipetting and assembly of encoded chemical-laden microparticles for high-throughput multiplexed bioassays.
    Eun Chung S; Kim J; Yoon Oh D; Song Y; Hoon Lee S; Min S; Kwon S
    Nat Commun; 2014 Mar; 5():3468. PubMed ID: 24632848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An impedance-based cell contraction assay using human primary smooth muscle cells and fibroblasts.
    Bravo DD; Chernov-Rogan T; Chen J; Wang J
    J Pharmacol Toxicol Methods; 2018; 89():47-53. PubMed ID: 29056519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A continuous protein methyltransferase (G9a) assay for enzyme activity measurement and inhibitor screening.
    Dhayalan A; Dimitrova E; Rathert P; Jeltsch A
    J Biomol Screen; 2009 Oct; 14(9):1129-33. PubMed ID: 19734436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput assay development for combined in vitro toxicity screening of hit compounds and their metabolites in early drug-discovery stage.
    Siricilla S
    Bioanalysis; 2017 Jul; 9(13):959-961. PubMed ID: 28708435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.